ArticleBMC ophthalmology2025
Therapeutic effect of suprachoroidal viscoelastic injection combined with 532 laser photocoagulation in treating rhegmatogenous retinal detachment.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A two-step approach for suprachoroidal delivery of dexamethasone implant using a custom-made injector.International journal of retina and vitreous · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess the therapeutic effect of suprachoroidal viscoelastic injection combined with 532 laser photocoagulation for the closure of retinal tears in the treatment of rhegmatogenous retinal detachment (RRD).
methodsWe retrospectively analyzed the clinical data of eight patients with RRD (eight eyes) who underwent suprachoroidal viscoelastic injection combined with 532-nm laser photocoagulation for the closure of tears at our hospital. The outcomes investigated were postoperative visual acuity and retinal reattachment.
resultsThe intraocular pressure (IOP) was significantly higher after surgery than before surgery (11.93 mmHg vs. 19.50 mmHg), and the best corrected visual acuity (BCVA) changed from 0.41 to 0.49, suggesting a significant improvement within 3 days post-surgery. In 7/8 eyes, the retina was well reattached postoperatively and follow-ups indicated stable condition. One patient experienced failed retinal reattachment and subsequently underwent vitrectomy combined with silicone oil tamponade. Three months after surgery, the silicone oil was removed, revealing successful reattachment of the retina.
conclusionIn patients with RRD characterized by smaller retinal tears, more localized retinal detachment, and a proliferative vitreoretinopathy grade of ≤ C1, treatment incorporating suprachoroidal viscoelastic injection and 532-nm laser photocoagulation to seal the tears resulted in good postoperative recovery, with all patients achieving favorable visual acuity. However, due to the retrospective, non-comparative design without a control group, it is difficult to fully evaluate the relative efficacy of this treatment compared to other methods. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.